GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (MEX:SOLV) » Definitions » EV-to-FCF

Solventum (MEX:SOLV) EV-to-FCF : 26.57 (As of Apr. 12, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Solventum EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Solventum's Enterprise Value is MXN385,262 Mil. Solventum's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was MXN14,499 Mil. Therefore, Solventum's EV-to-FCF for today is 26.57.

The historical rank and industry rank for Solventum's EV-to-FCF or its related term are showing as below:

MEX:SOLV' s EV-to-FCF Range Over the Past 10 Years
Min: 7.27   Med: 16.16   Max: 26.3
Current: 23.23

During the past 5 years, the highest EV-to-FCF of Solventum was 26.30. The lowest was 7.27. And the median was 16.16.

MEX:SOLV's EV-to-FCF is ranked worse than
50.65% of 387 companies
in the Medical Devices & Instruments industry
Industry Median: 22.93 vs MEX:SOLV: 23.23

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-12), Solventum's stock price is MXN1700.00. Solventum's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was MXN49.414. Therefore, Solventum's PE Ratio (TTM) for today is 34.40.


Solventum EV-to-FCF Historical Data

The historical data trend for Solventum's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum EV-to-FCF Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
- - - - 23.18

Solventum Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 12.70 10.86 16.54 23.18

Competitive Comparison of Solventum's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Solventum's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solventum's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Solventum's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Solventum's EV-to-FCF falls into.


;
;

Solventum EV-to-FCF Calculation

Solventum's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=385261.745/14498.985
=26.57

Solventum's current Enterprise Value is MXN385,262 Mil.
Solventum's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN14,499 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solventum  (MEX:SOLV) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Solventum's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1700.00/49.414
=34.40

Solventum's share price for today is MXN1700.00.
Solventum's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN49.414.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Solventum EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Solventum's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Solventum Business Description

Traded in Other Exchanges
Address
2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.